NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Nutex Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
42.9%
3M of 7M shares
Institutional holders
154
38 new, 12 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
5 buys · 1 sales
Net bought $104.74K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Topline Capital Management, LLC | 556,567 | 9.90% | 13G (passive) amendment | Jul 22, 2025 |
| Pertento Partners LLP | 405,029 | 5.90% | 13G (passive) amendment | May 1, 2026 |
| BlackRock, Inc. | 367,633 | 5.30% | 13G (passive) | Mar 31, 2026 |
| Pertento Advisors LLC | 361,988 | 5.20% | 13G (passive) | Mar 5, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NUTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Pertento Partners LLP | 451,310 | 6.59% | $77.12M | +77,340 | 4.16% |
| BlackRock, Inc. | 407,349 | 5.95% | $69.61M | +27,994 | 0.00% |
| American Century Companies Inc | 237,414 | 3.47% | $40.57M | +33,964 | 0.02% |
| Vanguard Capital Management LLC | 215,919 | 3.15% | $36.90M | −3,212 | 0.00% |
| Geode Capital Management, LLC | 132,049 | 1.93% | $22.57M | +9,936 | 0.00% |
| State Street Corp | 130,836 | 1.91% | $22.36M | +7,659 | 0.00% |
| D. E. Shaw & Co., Inc. | 97,454 | 1.42% | $16.65M | New | 0.01% |
| UBS Group AG | 77,912 | 1.14% | $13.31M | +8,342 | 0.00% |
| Winmill & Co. Inc | 65,350 | 0.95% | $11.17M | – | 2.47% |
| Focus Partners Wealth | 60,881 | 0.89% | $10.40M | New | 0.01% |
| Millennium Management LLC | 52,107 | 0.76% | $8.90M | −37,464 | 0.00% |
| Goldman Sachs Group Inc | 51,244 | 0.75% | $8.76M | +17,449 | 0.00% |
| Bridgeway Capital Management, LLC | 46,924 | 0.69% | $8.02M | +31,904 | 0.14% |
| Empowered Funds, LLC | 45,177 | 0.66% | $7.72M | +12,726 | 0.04% |
| Pacer Advisors, Inc. | 44,614 | 0.65% | $7.62K | +15,938 | 0.02% |
| Northern Trust Corp | 44,056 | 0.64% | $7.53M | +2,789 | 0.00% |
| Topline Capital Management, LLC | 41,764 | 0.61% | $7.14M | −136,036 | 1.85% |
| One Plus One Wealth Management, LLC | 40,441 | 0.59% | $6.91M | – | 2.98% |
| Vanguard Fiduciary Trust Co | 35,969 | 0.53% | $6.15M | +141 | 0.00% |
| Vanguard Portfolio Management LLC | 34,660 | 0.51% | $5.92M | −5,143 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 154 | 3M | 42.9% | 38 / 63 | 35 / 12 | 1M | 0M |
| Q1 2026 | 130 | 3M | 41.0% | 40 / 52 | 26 / 25 | 1M | 1M |
| Q4 2025 | 117 | 3M | 38.3% | 31 / 34 | 35 / 9 | 0M | 0M |
| Q3 2025 | 95 | 2M | 35.4% | 30 / 36 | 12 / 36 | 1M | 0M |
| Q2 2025 | 102 | 2M | 25.5% | 62 / 17 | 18 / 6 | 1M | 0M |
| Q1 2025 | 46 | 1M | 14.8% | 9 / 16 | 13 / 4 | 0M | 0M |
| Q4 2024 | 41 | 1M | 13.2% | 16 / 10 | 8 / 5 | 0M | 0M |
| Q3 2024 | 30 | 0M | 6.8% | 29 / 0 | 1 / 2 | 0M | 0M |
| Q2 2024 | 3 | 0M | 0.0% | 3 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NUTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Avantis U.S. Small Cap Value ETF | 185,385 | 2.71% | $23.94M | 0.09% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 153,182 | 2.24% | $26.18M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 131,382 | 1.92% | $22.45M | 0.03% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 57,700 | 0.84% | $9.86M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 54,851 | 0.80% | $8.09M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 47,087 | 0.69% | $8.05M | 0.05% | Jun 30, 2026 |
| Pacer US Small Cap Cash Cows 100 ETF | 44,170 | 0.65% | $6.51M | 0.18% | Jul 31, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 31,924 | 0.47% | $5.46M | 0.23% | Jun 30, 2026 |
| VictoryShares Small Cap Free Cash Flow ETF | 28,667 | 0.42% | $4.90M | 0.81% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 26,802 | 0.39% | $3.46M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 26,409 | 0.39% | $3.41M | 0.02% | May 31, 2026 |
| iShares Micro-Cap ETF | 16,858 | 0.25% | $2.88M | 0.19% | Jun 30, 2026 |
| First Trust Dow Jones Select MicroCap Index Fund | 16,671 | 0.24% | $2.85M | 1.07% | Jun 30, 2026 |
| Omni Small-Cap Value Fund | 15,000 | 0.22% | $2.56M | 0.19% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Health Care Services ETF | 13,849 | 0.20% | $2.37M | 1.69% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas T. Vo | Chief Executive Officer, Director | 28,809,974 | 420.71% | May 29, 2026 |
| Warren Hosseinion | President, Director | 61,739 | 0.90% | Mar 23, 2026 |
| Wesley Shane Bamburg | Chief Operating Officer | – | – | Mar 24, 2026 |
| Pamela W. Montgomery | Chief Legal Officer-Healthcare | 2,758 | 0.04% | Mar 16, 2026 |
| Michael L. Chang | Chief Medical Officer | 82,356 | 1.20% | Mar 11, 2026 |
| Elisa V. Luqman | Chief Legal Officer - SEC | 4,224 | 0.06% | Mar 11, 2026 |
| Jon Christian Bates | Chief Financial Officer | 8,305 | 0.12% | Mar 11, 2026 |
| Joshua DeTillio | Chief Operating Officer | 6,481 | 0.09% | Apr 14, 2025 |
| Scott J. Saunders | Director | 400 | 0.01% | Sep 18, 2026 |
| Cheryl Yvonne Grenas | Director | 10,670 | 0.16% | Aug 3, 2026 |
| Frank E. Jaumot | Director | 753 | 0.01% | Aug 3, 2026 |
| Michael Lee Reed | Director | 670 | 0.01% | Aug 3, 2026 |
| Kelvin Spears | Director | 34,656 | 0.51% | Jun 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Scott J. Saunders Director | Sep 18, 2026 | Sale | −203 | $214.25 | $43.49K | 400 |
| Michael Lee Reed Director | Jul 31, 2026 | Option exercise | +603 | – | – | 670 |
| Scott J. Saunders Director | Jul 31, 2026 | Option exercise | +603 | – | – | 603 |
| Frank E. Jaumot Director | Jul 31, 2026 | Option exercise | +603 | – | – | 753 |
| Cheryl Yvonne Grenas Director | Jul 31, 2026 | Option exercise | +603 | – | – | 670 |
| Kelvin Spears Director | Jun 4, 2026 | Other | +2,519 | – | – | 34,656 |
| Thomas T. Vo Chief Executive Officer, Director | May 28, 2026 | Other | +75,747 | – | – | 2,103,014 |
| Thomas T. Vo Chief Executive Officer, Director | Apr 9, 2026 | Other | +184,071 | – | – | 2,027,267 |
| Frank E. Jaumot Director | Mar 20, 2026 | Buy | +150 | $93.56 | $14.03K | 150 |
| Warren Hosseinion President, Director | Mar 19, 2026 | Buy | +252 | $94.07 | $23.71K | 7,765 |
| Kelvin Spears Director | Mar 17, 2026 | Buy | +10 | $94.46 | $945 | 32,137 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 13, 2026 | Buy | +79 | $88.87 | $7.02K | 2,758 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 10, 2026 | Tax withholding | −3,017 | $86.22 | $260.13K | 1,843,196 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 10, 2026 | Option exercise | +8,334 | – | – | 1,846,213 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 10, 2026 | Option exercise | +2,084 | – | – | 3,455 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 10, 2026 | Tax withholding | −776 | $86.22 | $66.91K | 2,679 |
| Michael L. Chang Chief Medical Officer | Mar 10, 2026 | Tax withholding | −769 | $86.22 | $66.30K | 82,356 |
| Michael L. Chang Chief Medical Officer | Mar 10, 2026 | Option exercise | +2,084 | – | – | 83,125 |
| Jon Christian Bates Chief Financial Officer | Mar 10, 2026 | Option exercise | +2,667 | – | – | 8,305 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 10, 2026 | Option exercise | +2,084 | – | – | 3,154 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 10, 2026 | Tax withholding | −784 | $86.22 | $67.60K | 2,370 |
| Warren Hosseinion President, Director | Mar 10, 2026 | Tax withholding | −3,274 | $86.22 | $282.28K | 7,513 |
| Warren Hosseinion President, Director | Mar 10, 2026 | Option exercise | +6,293 | – | – | 10,787 |
| Kelvin Spears Director | Mar 10, 2026 | Option exercise | +183 | – | – | 32,209 |
| Kelvin Spears Director | Mar 10, 2026 | Tax withholding | −82 | $86.22 | $7.07K | 32,127 |
| Jon Christian Bates Chief Financial Officer | Nov 25, 2025 | Buy | +750 | $136.71 | $102.53K | 5,638 |
| Jon Christian Bates Chief Financial Officer | Apr 8, 2025 | Buy | +1,000 | $81.81 | $81.81K | 4,888 |
| Michael L. Chang Chief Medical Officer | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 81,041 |
| Kelvin Spears Director | Apr 4, 2025 | Tax withholding | −34 | $72.10 | $2.45K | 31,992 |
| Warren Hosseinion President, Director | Apr 4, 2025 | Tax withholding | −1,072 | $72.10 | $77.29K | 3,422 |
| Thomas T. Vo Chief Executive Officer, Director | Apr 4, 2025 | Tax withholding | +895 | $72.10 | $64.53K | 1,837,879 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 1,371 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Apr 4, 2025 | Tax withholding | −24 | $72.10 | $1.73K | 387 |
| Elisa V. Luqman Chief Legal Officer - SEC | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 1,070 |
| Joshua DeTillio Chief Operating Officer | Apr 4, 2025 | Tax withholding | −452 | $72.10 | $32.59K | 6,481 |
| Michael L. Chang Chief Medical Officer | Mar 1, 2025 | Option exercise | +1,250 | – | – | 81,307 |
| Kelvin Spears Director | Mar 1, 2025 | Option exercise | +143 | – | – | 32,026 |
| Warren Hosseinion President, Director | Mar 1, 2025 | Option exercise | +3,776 | – | – | 4,494 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 1, 2025 | Option exercise | +5,000 | – | – | 1,838,774 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 1, 2025 | Option exercise | +1,250 | – | – | 1,637 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 1, 2025 | Option exercise | +111 | – | – | 411 |
| Jon Christian Bates Chief Financial Officer | Mar 1, 2025 | Option exercise | +111 | – | – | 2,388 |
| Jon Christian Bates Chief Financial Officer | Mar 1, 2025 | Option exercise | +1,500 | – | – | 3,888 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 1, 2025 | Option exercise | +1,250 | – | – | 1,336 |
| Joshua DeTillio Chief Operating Officer | Mar 1, 2025 | Option exercise | +2,125 | – | – | 6,933 |
| Thomas T. Vo Chief Executive Officer, Director | Jan 8, 2025 | Gift | +5,000 | – | – | 1,833,774 |
| Jon Christian Bates Chief Financial Officer | Aug 22, 2024 | Buy | +1,350 | $21.46 | $28.97K | 2,277 |
| Joshua DeTillio Chief Operating Officer | Aug 20, 2024 | Buy | +575 | $17.40 | $10.01K | 4,808 |
| Joshua DeTillio Chief Operating Officer | Aug 19, 2024 | Buy | +1,300 | $17.85 | $23.21K | 4,233 |
| Thomas T. Vo Chief Executive Officer, Director | Jul 12, 2024 | Award | +22,709 | – | – | 1,828,774 |
| Joshua DeTillio Chief Operating Officer | Jun 12, 2024 | Buy | +20,000 | $0.54 | $10.80K | 29,333 |
| Thomas T. Vo Chief Executive Officer, Director | May 30, 2024 | Buy | +2,986 | $0.66 | $1.97K | 18,060,663 |
| Thomas T. Vo Chief Executive Officer, Director | May 29, 2024 | Buy | +3,768 | $0.68 | $2.56K | 18,057,677 |
| Thomas T. Vo Chief Executive Officer, Director | May 28, 2024 | Buy | +48,394 | $0.70 | $33.88K | 18,053,909 |
| Thomas T. Vo Chief Executive Officer, Director | May 13, 2024 | Buy | +17,330 | $0.69 | $11.96K | 18,005,515 |
| Pamela W. Montgomery Chief Legal Officer | Mar 12, 2024 | Option exercise | +16,502 | – | – | 45,004 |
| Jon Christian Bates Chief Financial Officer | Mar 12, 2024 | Option exercise | +49,505 | – | – | 139,010 |
| Thomas T. Vo Chief Executive Officer, Director | Nov 20, 2023 | Buy | +275,200 | $0.23 | $63.30K | 269,822,776 |
| Thomas T. Vo Chief Executive Officer, Director | Nov 17, 2023 | Buy | +224,800 | $0.23 | $51.70K | 269,547,576 |
| Joshua DeTillio Chief Operating Officer | Nov 15, 2023 | Buy | +140,000 | $0.24 | $33.60K | 140,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.